How BPC-157 Promotes Tissue Repair

Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide originally isolated from human gastric juice. Its sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) has demonstrated broad cytoprotective and regenerative effects across multiple tissue types in over 100 preclinical studies.

Mechanism of Action

BPC-157 promotes tissue repair through several interconnected pathways:

• Angiogenesis: Upregulates vascular endothelial growth factor (VEGF) and its receptor VEGFR2, stimulating new blood vessel formation at injury sites.
• Nitric Oxide System: Modulates the NO system, which plays a central role in vasodilation, anti-inflammation, and wound healing signaling.
• Growth Hormone Receptor: Increases expression of GH receptors in injured tissue, amplifying the local regenerative response.
• Tendon-to-Bone Healing: In preclinical models, BPC-157 accelerated Achilles tendon healing, quadriceps repair, and medial collateral ligament recovery by promoting collagen organization and fibroblast proliferation.

Clinical Relevance

While human RCTs are limited, BPC-157's consistent efficacy across rodent models of tendon, ligament, muscle, nerve, and GI injury — combined with its favorable safety profile — has made it the most-prescribed peptide in optimization medicine. KAYU physicians prescribe BPC-157 (250-500mcg daily, subcutaneous or oral) for musculoskeletal recovery, post-surgical healing, and GI conditions such as inflammatory bowel presentations.

Safety Profile

No adverse effects have been reported in preclinical studies at therapeutic doses. BPC-157 was granted Category 1 status (restored February 2026) by the FDA, permitting continued compounding. It is not currently FDA-approved as a standalone drug.